{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T15:52:42Z","timestamp":1774453962064,"version":"3.50.1"},"reference-count":62,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Proton therapy requires accurate, reliable normal tissue complication probability (NTCP) models for treatment planning and evidence-based patient selection. This review examines 2 challenges in proton therapy: developing NTCP models that accurately reflect proton-specific toxicity and managing NTCP prediction uncertainty to ensure reliable clinical decision-making. Regarding model accuracy, photon-derived NTCP models work for some endpoints but fail for others when proton therapy exhibits distinct dose-response characteristics, indicating that the need for proton-specific models is endpoint-dependent. Clinical evidence that supports updating NTCP models by incorporating variable relative biological effectiveness is statistically weak due to interpatient heterogeneity and inconsistent findings. Despite ongoing efforts in improving NTCP prediction accuracy, the impact of prediction uncertainty on patient selection decisions has received limited attention. Further study is required to establish a robust, model-uncertainty-aware NTCP-guided patient selection framework for proton therapy that addresses both model accuracy and prediction confidence.<\/jats:p>","DOI":"10.1097\/ppo.0000000000000814","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T15:00:25Z","timestamp":1774450825000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Normal Tissue Complication Probability Modeling for Proton Therapy"],"prefix":"10.1097","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8108-9622","authenticated-orcid":false,"given":"Mei","family":"Chen","sequence":"first","affiliation":[{"name":"Thoracic Radiation Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongxing","family":"Liao","sequence":"additional","affiliation":[{"name":"Thoracic Radiation Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven J.","family":"Frank","sequence":"additional","affiliation":[{"name":"Radiation Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narayan","family":"Sahoo","sequence":"additional","affiliation":[{"name":"Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaorong R.","family":"Zhu","sequence":"additional","affiliation":[{"name":"Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2026,3]]},"reference":[{"key":"R1-20260325","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1093\/neuonc\/noab040","article-title":"A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma","volume":"23","author":"Brown","year":"2021","journal-title":"Neuro Oncol"},{"key":"R2-20260325","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ijrobp.2016.02.027","article-title":"Randomized clinical trial comparing proton beam radiation therapy with transarterial chemoembolization for hepatocellular carcinoma: results of an interim analysis","volume":"95","author":"Bush","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R3-20260325","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ijrobp.2024.08.012","article-title":"Prostate advanced radiation technologies investigating quality of life (PARTIQoL): phase III randomized clinical trial of proton therapy vs. IMRT for localized prostate cancer","volume":"120","author":"Efstathiou","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R4-20260325","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1200\/JCO.19.02503","article-title":"Randomized phase IIB trial of proton beam therapy versus intensity-modulated radiation therapy for locally advanced esophageal cancer","volume":"38","author":"Lin","year":"2020","journal-title":"J Clin Oncol"},{"key":"R5-20260325","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.radonc.2022.08.014","article-title":"A systematic review of clinical studies on variable proton relative biological effectiveness (RBE)","volume":"175","author":"Underwood","year":"2022","journal-title":"Radiother Oncol"},{"key":"R6-20260325","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ijrobp.2019.02.039","article-title":"Spatial dose patterns associated with radiation pneumonitis in a randomized trial comparing intensity-modulated photon therapy with passive scattering proton therapy for locally advanced non-small cell lung cancer","volume":"104","author":"Palma","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R7-20260325","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.radonc.2011.11.006","article-title":"External validation of three dimensional conformal radiotherapy based NTCP models for patient-rated xerostomia and sticky saliva among patients treated with intensity modulated radiotherapy","volume":"105","author":"Beetz","year":"2012","journal-title":"Radiother Oncol"},{"key":"R8-20260325","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.radonc.2016.08.022","article-title":"Toward a model-based patient selection strategy for proton therapy: external validation of photon-derived normal tissue complication probability models in a head and neck proton therapy cohort","volume":"121","author":"Blanchard","year":"2016","journal-title":"Radiother Oncol"},{"key":"R9-20260325","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.radonc.2014.09.013","article-title":"Development of a multivariable normal tissue complication probability (NTCP) model for tube feeding dependence after curative radiotherapy\/chemo-radiotherapy in head and neck cancer","volume":"113","author":"Wopken","year":"2014","journal-title":"Radiother Oncol"},{"key":"R10-20260325","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.radonc.2011.08.009","article-title":"Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study","volume":"105","author":"Christianen","year":"2012","journal-title":"Radiother Oncol"},{"key":"R11-20260325","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.radonc.2012.03.004","article-title":"NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors","volume":"105","author":"Beetz","year":"2012","journal-title":"Radiother Oncol"},{"key":"R12-20260325","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1016\/j.ijrobp.2012.05.020","article-title":"A prospective cohort study on radiation-induced hypothyroidism: development of an NTCP model","volume":"84","author":"Boomsma","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R13-20260325","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.radonc.2011.12.027","article-title":"Dose-response analysis of acute oral mucositis and pharyngeal dysphagia in patients receiving induction chemotherapy followed by concomitant chemo-IMRT for head and neck cancer","volume":"103","author":"Bhide","year":"2012","journal-title":"Radiother Oncol"},{"key":"R14-20260325","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.phro.2022.09.005","article-title":"Independent validation of a dysphagia dose response model for the selection of head and neck cancer patients to proton therapy","volume":"24","author":"Kalendralis","year":"2022","journal-title":"Phys Imaging Radiat Oncol"},{"key":"R16-20260325","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.radonc.2019.09.017","article-title":"Cross-modality applicability of rectal normal tissue complication probability models from photon- to proton-based radiotherapy","volume":"142","author":"Pedersen","year":"2020","journal-title":"Radiother Oncol"},{"key":"R17-20260325","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/j.ijrobp.2009.03.078","article-title":"Radiation dose-volume effects in radiation-induced rectal injury","volume":"76","author":"Michalski","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R18-20260325","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.3109\/0284186X.2010.509736","article-title":"Normal tissue complication probability (NTCP) modeling of late rectal bleeding following external beam radiotherapy for prostate cancer: a test of the QUANTEC-recommended NTCP model","volume":"49","author":"Liu","year":"2010","journal-title":"Acta Oncol"},{"key":"R19-20260325","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0360-3016(91)90172-Z","article-title":"Fitting of normal tissue tolerance data to an analytic function","volume":"21","author":"Burman","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R20-20260325","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.radonc.2011.10.022","article-title":"Parameters for the Lyman Kutcher Burman (LKB) model of normal tissue complication probability (NTCP) for specific rectal complications observed in clinical practise","volume":"102","author":"Gulliford","year":"2012","journal-title":"Radiother Oncol"},{"key":"R21-20260325","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2004.08.013","article-title":"Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101)","volume":"73","author":"Rancati","year":"2004","journal-title":"Radiother Oncol"},{"key":"R22-20260325","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.ijrobp.2006.10.014","article-title":"Incidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose-based and dose-volume-based normal tissue complication probability models","volume":"67","author":"S\u00f6hn","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R23-20260325","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.radonc.2016.04.005","article-title":"Normal tissue complication probability (NTCP) models for late rectal bleeding, stool frequency and fecal incontinence after radiotherapy in prostate cancer NTCP models for anorectal side effects patients","volume":"119","author":"Schaake","year":"2016","journal-title":"Radiother Oncol"},{"key":"R24-20260325","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ijrobp.2020.12.052","article-title":"Combining clinical and dosimetric features in a PBS proton therapy cohort to develop a NTCP model for radiation-induced optic neuropathy","volume":"110","author":"K\u00f6the","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R25-20260325","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.ijrobp.2009.07.1753","article-title":"Radiation dose\u2013volume effects of optic nerves and chiasm","volume":"76","author":"Mayo","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R26-20260325","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1748-717X-6-61","article-title":"A comparison of dose-response characteristics of four NTCP models using outcomes of radiation-induced optic neuropathy and retinopathy","volume":"6","author":"Moiseenko","year":"2011","journal-title":"Radiat Oncol"},{"key":"R27-20260325","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.radonc.2020.03.003","article-title":"Lyman\u2013Kutcher\u2013Burman normal tissue complication probability modeling for radiation-induced esophagitis in non-small cell lung cancer patients receiving proton radiotherapy","volume":"146","author":"Wang","year":"2020","journal-title":"Radiother Oncol"},{"key":"R28-20260325","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.radonc.2005.10.001","article-title":"Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer","volume":"77","author":"Chapet","year":"2005","journal-title":"Radiother Oncol"},{"key":"R29-20260325","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2005.03.021","article-title":"Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy","volume":"75","author":"Belderbos","year":"2005","journal-title":"Radiother Oncol"},{"key":"R30-20260325","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1080\/0284186X.2019.1654129","article-title":"NTCP model validation method for DAHANCA patient selection of protons versus photons in head and neck cancer radiotherapy","volume":"58","author":"Hansen","year":"2019","journal-title":"Acta Oncol"},{"key":"R31-20260325","doi-asserted-by":"crossref","first-page":"e330","DOI":"10.1016\/j.prro.2020.04.005","article-title":"Updating photon-based normal tissue complication probability models for pneumonitis in patients with lung cancer treated with proton beam therapy","volume":"10","author":"Jain","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"R32-20260325","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.ijrobp.2009.06.091","article-title":"Radiation dose-volume effects in the lung","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R33-20260325","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3109\/0284186X.2013.820341","article-title":"Towards individualized dose constraints: adjusting the QUANTEC radiation pneumonitis model for clinical risk factors","volume":"53","author":"Appelt","year":"2014","journal-title":"Acta Oncol"},{"key":"R34-20260325","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/S0167-8140(17)30583-2","article-title":"Updating QUANTEC and clinically adjusted QUANTEC models for pneumonitis at external validation","volume":"123","author":"Van Der Schaaf","year":"2017","journal-title":"Radiother Oncol"},{"key":"R35-20260325","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1002\/sim.7179","article-title":"A closed testing procedure to select an appropriate method for updating prediction models","volume":"36","author":"Vergouwe","year":"2017","journal-title":"Stat Med"},{"key":"R36-20260325","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.phro.2021.10.004","article-title":"Normal tissue complication probability models for prospectively scored late rectal and urinary morbidity after proton therapy of prostate cancer","volume":"20","author":"Pedersen","year":"2021","journal-title":"Phys Imaging Radiat Oncol"},{"key":"R37-20260325","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.radonc.2018.06.036","article-title":"Development and validation of NTCP models for acute side-effects resulting from proton beam therapy of brain tumours","volume":"130","author":"Dutz","year":"2019","journal-title":"Radiother Oncol"},{"key":"R38-20260325","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ijrobp.2022.01.047","article-title":"NTCP modeling for high-grade temporal radionecroses in a large cohort of patients receiving pencil beam scanning proton therapy for skull base and head and neck tumors","volume":"113","author":"Schr\u00f6der","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R39-20260325","doi-asserted-by":"crossref","first-page":"R419","DOI":"10.1088\/0031-9155\/59\/22\/R419","article-title":"Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer","volume":"59","author":"Paganetti","year":"2014","journal-title":"Phys Med Biol"},{"key":"R40-20260325","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1002\/mp.13390","article-title":"Report of the AAPM TG-256 on the relative biological effectiveness of proton beams in radiation therapy","volume":"46","author":"Paganetti","year":"2019","journal-title":"Med Phys"},{"key":"R41-20260325","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.radonc.2016.11.001","article-title":"Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma","volume":"121","author":"Peeler","year":"2016","journal-title":"Radiother Oncol"},{"key":"R42-20260325","doi-asserted-by":"crossref","first-page":"225020","DOI":"10.1088\/1361-6560\/ab3841","article-title":"A Monte Carlo based radiation response modelling framework to assess variability of clinical RBE in proton therapy","volume":"64","author":"Eulitz","year":"2019","journal-title":"Phys Med Biol"},{"key":"R43-20260325","doi-asserted-by":"crossref","first-page":"109422","DOI":"10.1016\/j.radonc.2022.11.011","article-title":"Increased relative biological effectiveness and periventricular radiosensitivity in proton therapy of glioma patients","volume":"178","author":"Eulitz","year":"2023","journal-title":"Radiother Oncol"},{"key":"R44-20260325","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1080\/0284186X.2019.1631477","article-title":"Predicting late magnetic resonance image changes in glioma patients after proton therapy","volume":"58","author":"Eulitz","year":"2019","journal-title":"Acta Oncol"},{"key":"R45-20260325","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ijrobp.2020.03.013","article-title":"Late contrast enhancing brain lesions in proton-treated patients with low-grade glioma: clinical evidence for increased periventricular sensitivity and variable RBE","volume":"107","author":"Bahn","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R46-20260325","doi-asserted-by":"crossref","first-page":"111271","DOI":"10.1016\/j.radonc.2025.111271","article-title":"Model validation confirms variable relative biological effectiveness and elevated periventricular sensitivity after proton therapy of brain tumors","volume":"214","author":"Palkowitsch","year":"2026","journal-title":"Radiother Oncol"},{"key":"R47-20260325","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijrobp.2020.08.058","article-title":"Brain necrosis in adult patients after proton therapy: is there evidence for dependency on linear energy transfer?","volume":"109","author":"Niemierko","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R48-20260325","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijrobp.2021.08.027","article-title":"Correlation of LET with MRI changes in brain and potential implications for normal tissue complication probability for patients with meningioma treated with pencil beam scanning proton therapy","volume":"112","author":"Bertolet","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R49-20260325","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.radonc.2021.08.015","article-title":"Study of relationship between dose, LET and the risk of brain necrosis after proton therapy for skull base tumors","volume":"163","author":"Garbacz","year":"2021","journal-title":"Radiother Oncol"},{"key":"R50-20260325","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ijrobp.2021.06.016","article-title":"Mixed effect modeling of dose and linear energy transfer correlations with brain image changes after intensity modulated proton therapy for skull base head and neck cancer","volume":"111","author":"Engeseth","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R51-20260325","doi-asserted-by":"crossref","first-page":"110716","DOI":"10.1016\/j.radonc.2025.110716","article-title":"Mixed effect model confirms increased risk of image changes with increasing linear energy transfer in proton therapy of gliomas","volume":"204","author":"Vestergaard","year":"2025","journal-title":"Radiother Oncol"},{"key":"R52-20260325","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1002\/mp.14989","article-title":"A framework for voxel-based assessment of biological effect after proton radiotherapy in pediatric brain cancer patients using multi-modal imaging","volume":"48","author":"Skaarup","year":"2021","journal-title":"Med Phys"},{"key":"R53-20260325","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.ijrobp.2021.02.018","article-title":"Brain-specific relative biological effectiveness of protons based on long-term outcome of patients with nasopharyngeal carcinoma","volume":"110","author":"Zhang","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R54-20260325","doi-asserted-by":"crossref","first-page":"843175","DOI":"10.3389\/fonc.2022.843175","article-title":"Empirical relative biological effectiveness (RBE) for mandible osteoradionecrosis (ORN) in head and neck cancer patients treated with pencil-beam-scanning proton therapy (PBSPT): a retrospective, case-matched cohort study","volume":"12","author":"Yang","year":"2022","journal-title":"Front Oncol"},{"key":"R56-20260325","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.ijrobp.2021.02.024","article-title":"Exploratory investigation of dose-linear energy transfer (LET) volume histogram (DLVH) for adverse events study in intensity modulated proton therapy (IMPT)","volume":"110","author":"Yang","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R57-20260325","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1002\/mp.17745","article-title":"Study of linear energy transfer effect on rib fracture in breast cancer patients receiving pencil-beam-scanning proton therapy","volume":"52","author":"Yang","year":"2025","journal-title":"Med Phys"},{"key":"R58-20260325","doi-asserted-by":"crossref","first-page":"100466","DOI":"10.1016\/j.phro.2023.100466","article-title":"Linear energy transfer-inclusive models of brainstem necrosis following proton therapy of paediatric ependymoma","volume":"27","author":"Handeland","year":"2023","journal-title":"Phys Imaging Radiat Oncol"},{"key":"R59-20260325","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2013.05.007","article-title":"Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach","volume":"107","author":"Langendijk","year":"2013","journal-title":"Radiother Oncol"},{"key":"R60-20260325","doi-asserted-by":"crossref","first-page":"354","DOI":"10.14338\/IJPT-20-00089.1","article-title":"National protocol for model-based selection for proton therapy in head and neck cancer","volume":"8","author":"Langendijk","year":"2021","journal-title":"Int J Part Ther"},{"key":"R61-20260325","doi-asserted-by":"crossref","first-page":"109812","DOI":"10.1016\/j.radonc.2023.109812","article-title":"Evaluation of decentralised model-based selection of head and neck cancer patients for a proton treatment study. DAHANCA 35","volume":"190","author":"Hansen","year":"2024","journal-title":"Radiother Oncol"},{"key":"R62-20260325","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.radonc.2017.09.028","article-title":"The impact of treatment accuracy on proton therapy patient selection for oropharyngeal cancer patients","volume":"125","author":"Arts","year":"2017","journal-title":"Radiother Oncol"},{"key":"R63-20260325","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1080\/0284186X.2017.1355113","article-title":"Impact of model and dose uncertainty on model-based selection of oropharyngeal cancer patients for proton therapy","volume":"56","author":"Bijman","year":"2017","journal-title":"Acta Oncol"},{"key":"R64-20260325","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.radonc.2019.03.003","article-title":"The normal tissue complication probability model-based approach considering uncertainties for the selective use of radiation modality in primary liver cancer patients","volume":"135","author":"Prayongrat","year":"2019","journal-title":"Radiother Oncol"}],"container-title":["The Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PPO.0000000000000814","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T15:00:32Z","timestamp":1774450832000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PPO.0000000000000814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":62,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ppo.0000000000000814","relation":{},"ISSN":["1540-336X"],"issn-type":[{"value":"1540-336X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"2025-12-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}